Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics Artwork

Medtech Talk

A weekly conversation with the innovators who will change how health care is delivered.

Medtech Talk

Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics

July 21, 2016 • Healthegy

Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick explains what it took to get the approval and how the company will sell going forward.